Advantage Alpha Capital Partners »

Emergent BioSolutions shares owned by Advantage Alpha Capital Partners

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Advantage Alpha Capital Partners from 13F filings

Historical chart of Advantage Alpha Capital Partners investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Advantage Alpha Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $405k 46k 8.82

More positions owned by Advantage Alpha Capital Partners

Ftai Aviation SHS (FTAI)
Avidxchange Holdings (AVDX)
Zeta Global Holdings Corp Cl A (ZETA)
Privia Health Group (PRVA)
CECO Environmental (CECO)
Harrow Health (HROW)
Global Business Travel Group Com Cl A (GBTG)
Casella Waste Sys Cl A (CWST)
Healthequity (HQY)
Kirby Corporation (KEX)
Knowles (KN)
Chart Industries (GTLS)
Firstcash Holdings (FCFS)
First American Financial (FAF)
Concentra Group Holdings Par Common Stock (CON)

View all positions for Advantage Alpha Capital Partners

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Palisade Capital Management
Charles Schwab Investment Management
Geode Capital Management
Acadian Asset Management
Connor, Clark & Lunn Investment Management
Marshall Wace
LSV Asset Management
Prescott Group Capital Management
Morgan Stanley

View all funds holding Emergent BioSolutions